Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other financing activities (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Other financing activities for 4 consecutive years, with $353480.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities fell 30.18% to $353480.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $958835.0 through Dec 2025, down 24.02% year-over-year, with the annual reading at $1.8 million for FY2025, 40.42% up from the prior year.
  • Other financing activities for Q4 2025 was $353480.0 at bioAffinity Technologies, up from $67132.0 in the prior quarter.
  • The five-year high for Other financing activities was $506304.0 in Q4 2024, with the low at $26685.0 in Q2 2022.
  • Average Other financing activities over 4 years is $197984.5, with a median of $186066.0 recorded in 2023.
  • The sharpest move saw Other financing activities skyrocketed 538.02% in 2023, then crashed 63.85% in 2025.
  • Over 4 years, Other financing activities stood at $36847.0 in 2022, then skyrocketed by 536.44% to $234510.0 in 2023, then surged by 115.9% to $506304.0 in 2024, then tumbled by 30.18% to $353480.0 in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $353480.0, $67132.0, and $211607.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.